Radioimmunoassays for five oestrogen metabolites in urine are described; they are oestrone 3-glucuronide, oestradiol 3-glucuronide, oestradiol 17,B-glucuronide, oestriol 3-glucuronide and oestriol 16a-glucuronide. These assays have proved accurate and reliable and can be performed rapidly; they have been carried out directly in diluted menstrual-cycle urine and pregnancy urine. No sample pretreatment was required. Preliminary results suggest that clinically useful information can be obtained by performing these assays on random urine specimens.
Radioimmunoassays for five oestrogen metabolites in urine are described; they are oestrone 3-glucuronide, oestradiol 3-glucuronide, oestradiol 17,B-glucuronide, oestriol 3-glucuronide and oestriol 16a-glucuronide. These assays have proved accurate and reliable and can be performed rapidly; they have been carried out directly in diluted menstrual-cycle urine and pregnancy urine. No sample pretreatment was required. Preliminary results suggest that clinically useful information can be obtained by performing these assays on random urine specimens.
The production of antisera against steroid-protein complexes has encouraged the measurement of steroid hormones and metabolites in blood, and this tendency has to some extent replaced more traditional methods of urine assay (Buster & Abraham, 1975) . However,-in some clinical situations the integrated measurement of steroid production, such as is given by urine assay, is of greater significance. The rapid clearance of steroid glucuronides by the kidney (Smith, 1966) makes the measurement of these conjugates in urine a useful clinical parameter. In the past analysis of steroids in urine has required the hydrolysis of conjugates before determination, a process that destroys the identity of the conjugate and can result in procedural loss. The immunoassay of steroid glucuronides not only avoids the hydrolysis step but also eliminates the subsequent extraction and purification before measurement. Moreover, in this form of assay the specificity is improved in other ways. The extra immunochemical determinant that the glucuronide substituent provides enables antibodies to discriminate better between similar conjugates. In forming the steroid glucuronide-protein immunogenic complex there is no need to introduce an artificial bridge, as a linkage to the protein carrier can be made through the existing carboxyl group of the glucuronyl moiety. In the radioimmunoassay of free steroids the use of an artificial bridge, e.g. hemisuccinate or carboxymethyl oxime, has given rise to strong cross-reactions with similar steroids differing at the position of conjugation (Bolton & Rutherford, 1976) . Finally, the availability of 3H-labelled steroid glucuronides makes it possible to use a labelled ligand that closely resembles the complete hapten conjugate. Jeffcoate et al. (1975) have shown that close resemblance between the hapten and bridge and the labelled ligand has advantages over radioimmunoassay systems where the labelled ligand resembles the hapten only.
For these reasons the radioimmunoassay of steroid glucuronides in urine has considerable practical advantage. Urines are simply diluted extensively before assay, a step that greatly minimizes interference from cross-reacting compounds. Antisera against five different steroid glucuronides, oestrone 3-glucuronide, oestradiol 3-glucuronide, oestriol 3-glucuronide, oestradiol 1 7f,-glucuronide and oestriol 16a-glucuronide have been prepared in this laboratory together with their corresponding 3H-labelled steroid glucuronides (Kellie, 1975) . The present paper describes the validation and application of the five glucuronide assays to determinations on human female urine both throughout the menstrual cycle and during pregnancy.
An important factor contributing to the preference of measurements of steroids in blood to those in urine has been the inconvenience and inaccuracy associated with the collection of 24h urine samples. The paper describes ways of obtaining useful information from random urine samples.
Experimental

Materials
Unless otherwise stated, reagents were purchased from Fisons Scientific Apparatus, Loughborough, Leics., U.K.
Steroid glucuronides, used as assay standards and for preparing immunogens, were available in the Department, having been previously synthesized (Foggitt & Kellie, 1964; Elce et al., 1967 (Samarajeewa & Kellie, 1975) Steroid antisera. Oestrogen glucuronides conjugated to bovine serum albumin were prepared by the method of Erlanger et al. (1959) . Antisera against these immunogens were available in the Department and had been raised as described by Samarajeewa & Kellie (1975) . The dilutions of antisera used in the assays were as follows: anti-(oestrone 3-glucuronide), anti-(oestradiol 3-glucuronide), anti-(oestradiol 17fi-glucuronide) and anti-(oestriol 3-glucuronide) were initially diluted with assay buffer by a factor of 50000 and anti-(oestriol 16a-glucuronide) was diluted by a factor of 13 000. The assay buffer was phosphate buffer (9.57g of Na2HPO4 and 5.08g of NaH2PO4,2H20 per litre) containing 0.9% NaCl, 0.1 % NaN3 and 0.1 % gelatine and made up in deionized water to pH7.0. Dextran/charcoal suspension, consisting of 1 % Norit SX1 charcoal and 0.15 % Dextran T40 (Pharmacia Fine Chemicals AB, Uppsala, Sweden) in assay buffer, was made up fresh on the day of use, but at least 30min before required. The suspension was continuously stirred on ice during dispensing. The scintillation fluid used contained 0.5 % 2,5-diphenyloxazole (Intertechnique, Uxbridge, Middx., U.K.) and 0.01 % 1,4-bis-(5-phenyloxazol-2-yl)benzene in a toluene/Triton X-100 mixture (3: 1, v/v).
All glassware was initially pretreated with a 1 % solution of dichlorodimethylsilane in toluene, then rinsed successively in toluene, methanol and water. Thereafter cleaning was performed by soaking in a 1 % solution of detergent (Divolab; Diversey Ltd., Barnet, Herts. EN4 OBU, U.K.) overnight, then rinsing in tap water and water, and finally drying in an oven at 60°C.
Urines. Successive daily urine collections were made throughout a complete menstrual cycle by 11 women volunteers with apparently normal menstrual cycles. Early-morning specimens were collected separately from those of the remainder of each 24h period. Urine volumes and times of collection were recorded, the specimens were preserved with 0.1 % NaN3 and stored at -15°C. One subject failed to complete all collections, another became pregnant during the cycle and has since given birth to a healthy baby. Two pregnant women (gestation over 16 weeks) volunteered to provide 24h urine collections at 2-6 week intervals during the course of pregnancy.
Methods
Before assay, urine samples were simply diluted with assay buffer. For menstrual-cycle urines 100-fold dilutions were necessary for oestrone 3-glucuronide and oestriol 3-glucuronide assays and 20-fold dilutions were necessary for the oestradiol 3-glucuronide, oestradiol 17fi-glucuronide and oestriol 16a-glucuronide assays. Pregnancy urines were diluted either 1000-or 10000-fold. Standard solutions of steroid glucuronides were prepared in assay buffer over the range 20-20000nM and stored at 4°C. For a chosen urine dilution, steroid standards were selected over an appropriate range and diluted by the same factor with assay buffer.
A similar assay procedure was followed for each of the five conjugates. Suitably diluted urine or standard (I00,ul) was transferred in duplicate to 75mm x 12mm glass test tubes and I 0gl (5nCi) of a solution of the labelled ligand in assay buffer and 100,1 of diluted antiserum were added. The tubes were vortex-mixed, capped with Parafilm and incubated at 37°C for 1 h, then placed in an ice bath for 30min. Dextran/ charcoal suspension (200, u1) was added, and the tubes were left for 15 min on ice before centrifugation (7500g-min) at 4°C. Supernatant (250p1) was removed from each tube and counted for radioactivity in 2.5 ml of scintillation fluid. Calibration graphs were plotted as the log of the amount of non-radioactive conjugate against the percentage inhibition of labelled ligand binding.
Determination of oestrogen glucuronide standards by a chemical method. Standard solutions (20-2000nM) of oestrone 3-glucuronide, oestriol 16a-glucuronide and oestriol 3-glucuronide were analysed for total oestrogen by the method of Brown et al. (1968) . Results are not corrected for procedural loss.
Plasma lutropin assay. Plasma lutropin was determined by radioimmunoassay on successive days, in five subjects, over the mid-cycle period during the time of urine collection. 1979
DIRECT RADIOIMMUNOASSAY OF OESTROGEN GLUCURONIDES
Creatinine determination. Creatinines were determined by the automated method of Chasson et al. (1961) .
Results
Assay characteristics are given in Table 1 . Sensitivity is defined as the dose of steroid that can be distinguished from zero dose of unlabelled steroid at the 95 % level of confidence. Intra-assay coefficients of variation were calculated from duplicate determinations on urine samples (Cekan, 1975) . Inter-assay coefficients of variation were calculated from successive determinations on a quality-control urine.
Accuracy of the methods was established by both internal and external recovery experiments. Determinations made on pooled urine over a range of dilutions resulted in a constant recovery of steroid (within the error limits shown in Table 1 ), provided that the unknowns were within the working range of the standard curve (i.e. between 20 and 80% inhibition of labelled-ligand binding). There was a linear relationship between the volume of urine assayed and measured steroid, as shown by the internal recovery correlation coefficients. Sample blanks performed over the same range of urine dilutions were not significantly different (P <0.05) from buffer blanks provided that urine was diluted 20-fold or greater.
External recovery experiments were performed by assaying increasing amounts of standard steroid added to the appropriate dilution of both charcoaltreated urine and pooled urine. Regression analysis (Table 2 ) indicated a linear relationship between added and recovered steroid. Recovery ranged from 92 to 123 %.
Specificity of the various antisera was examined to assess the degree to which similar steroids would interfere with the assay. Cross-reactions are given in Table 3 and are calculated on a molar basis, as suggested by Davis & Loriaux (1975) . They were assessed Table 1 . Assay characteristics Sensitivity is the dose of steroid that can be distinguished from zero dose at the 95% level of confidence. Intra-assay precision was determined as the mean coefficient of variation of 60 duplicate samples. Inter-assay precision was determined as the coefficient of variation of successive estimations of a quality control urine (number of assays in parentheses). The internal recovery correlation coefficient tests proportionality between the dilution of urine assayed and the measured steroid. The recovery coefficient of variation is the precision of estimating steroid concentration over a range of urine dilutions. (Baker, 1977) .
Conjugate
Excretion of oestrogen glucuronides throughout the menstrual cycle The patterns ofexcretion ofoestrone 3-glucuronide, oestriol 3-glucuronide and oestriol 16cx-glucuronide were assessed on a daily basis throughout a menstrual cycle in nine subjects. Similarly oestradiol 3-glucuronide and oestradiol 17fl-glucuronide were assessed in five subjects. The results are expressed in Figs. l(b) , 1(e), l(d), l(c) and l(a) respectively. As each daily collection consisted of a daytime and an earlymorning specimen, the two measurements were totalled to give mass excreted for each day of the cycle. Unfortunately this daily period of collection was only approx. 24h (s.D.±1.4h). For the nine subjects cycle length ranged from 27 to 31 days, and where possible days of the cycle between different individuals were aligned relative to the plasma lutropin peak. In five women the day on which the lutropin peak occurred was designated day 0, the menses started on day 0+14; for the remaining women day 0 was determined by counting back 15 days from the start of the menses. The values given in Fig. 1 are mean values calculated on each day of the cycle for all the subjects investigated; standard deviations about the mean are also given.
The daily urinary excretion of pregnanediol 3-glucuronide was also measured in the nine women by direct radioimmunoassay (Baker et al., 1976) . In each case a value of 9umol/24h was exceeded during the luteal phase, indicating adequate corpus-luteum function. Mean values±s.D. are shown in Fig. 2 for the mass of pregnanediol 3-glucuronide excreted per 24h.
The pattern of excretion of the five oestrogen conjugates was characterized by a low fairly constant output during the mid-follicular phase between days -12 and -5. Excretion then rose to a pre-ovulatory maximum between days -2 and 0 followed by a fall over the next 2 or 3 days. During the luteal phase mass excreted was variable but was higher than during the follicular phase; only with oestriol 3-glucuronide did it rise higher than the mid-cycle peak. Excretion of the five conjugates consistently fell over days +12 to +14; the fall continued over the first 2 days at the beginning of the cycle.
For each subject, daily values for all measured conjugates were totalled. 'Totalled oestrogen' ranges are shown for three stages of the menstrual cycle in Table 4 (Table 5 ).
There was a large range of values about the mean daily excretion for each metabolite, particularly during the late follicular and the luteal phase. This reflects variation between different subjects rather than experimental error or day-to-day variation for one subject. Table 6 expresses each oestrogen conjugate as a percentage of 'totalled oestrogen' for eight women. The values given are mean percentages, averaged over one menstrual cycle, together with their respective standard deviations. The percentage of each oestrogen glucuronide excreted remains fairly constant over the menstrual cycle for a given individual (mean coefficient of variation = 23 %), whereas up to a fivefold difference can exist for the excretion of a particular metabolite between the eight women (mean coefficient of variation = 40 %). Since there is only limited variation in the proportion of any one conjugate throughout the menstrual cycle, the measurement of only one conjugate out of the five should be adequate to monitor the mid-cycle surge of oestrogen. To establish which would be the most useful conjugate to measure for this purpose, the ratio of the mid-cycle peak height to the follicularphase baseline was determined for each subject by dividing the mean value on days -2, -1 and 0 by the mean value on days -12 to -6 inclusive. The ratios were then averaged for all subjects, and the results are shown in Table 7 , together with their standard deviations, for each of the five metabolites. In addition, the day of the cycle on which the mid-cycle peak occurred was also recorded for each oestrogen conjugate.
This study was further extended by examining the ability to detect the mid-cycle rise. The mean and standard deviations of the follicular-phase baseline values (days -12 to -6) were calculated for each subject and each metabolite. A significant rise in the excretion of each conjugate was judged to be when the measured value exceeded two standard deviations above the mean of the baseline value. the day of the cycle and the number of subjects for which a significant increase in oestrogen excretion takes place.
The relative magnitude of the oestrogen glucuronVol. 177 ide peak compared with the baseline, the day on which the peak occurs and the time at which a significant surge occurs, follow a similar pattern, dependent on the nature of the metabolite. The successive events are: oestradiol 17fi-glucuronide, oestrone 3-glucuronide and oestradiol 3-glucuronide together, oestriol 16a-glucuronide, then oestriol 3-glucuronide.
Inconsistencies in the timing of '24h' urine collections, together with a desire to obtain useful information from random urine samples, led to an alternative means of expressing excretion of oestrogen glucuronides. The integrated rate of excretion was determined in a typical cycle by dividing the mass of metabolite in each daytime and early-morning urine specimen by the exact time period of collection, thus giving a result in nmol/h. The results are shown in Figs. 3(a) and 3(b) for oestrone 3-glucuronide and oestriol 16a-glucuronide respectively. There is no obvious diurnal variation between daytime and early-morning collections. However, there is a suggestion of episodic excretion of oestriol 16a-glucuronide during the luteal phase, which is partially disguised by expressing results as excretion per 24h.
An alternative means of avoiding 24h urine collections is to express results as steroid/creatinine ratios.
Figs. 3(a) and 3(b) compare the excretion rates (nmol/h) of oestrone 3-glucuronide and oestriol 3-glucuronide in one cycle with the steroid/creatinine ratio; correlation coefficients were respectively 0.929 (n = 52) and 0.949 (n = 52).
Oestrogen glucuronide/pregnanediol 3-glucuronide ratios, being independent of urine volume, may provide a means of assessing the mid-cycle oestrogen surge on random urine samples. Mean and range [oestrone 3-glucuronide]/[pregnanediol 3-glucuronide] values across the menstrual cycle are plotted for nine women (Fig. 4) . The assay was not designed to measure follicular-phase pregnanediol 3-glucuronide with great precision, therefore measured pregnanediol 3-glucuronide concentrations of less than 1UM were set equal to 1 UM in calculating the ratios. (A concentration of 1 AM could be distinguished from zero at the 99 % level of confidence.) In all nine subjects (Table 8 ) a significant increase (P<0.05) in the ratio was detected 48-120h before the lutropin peak. Excretion ofoestrogen glucuronide during pregnancy Fig. 5 shows the pattern of oestrogen glucuronides excreted in a subject who became pregnant during investigation. The notable difference from a nonpregnant subject is the increasing excretion of each conjugate during days +12, +13 and +14.
The excretion patterns of oestrone 3-glucuronide, oestriol 3-glucuronide and oestriol 16a-glucuronide during two normal pregnancies are depicted in Figs. 6(a) and 6(b). The output of oestriol 16a-glucuronide rises steadily after 20 weeks gestation and reaches a peak at, or just before, term; at this time it is some 2000-fold greater than normal luteal-phase excretion. Oestriol 3-glucuronide shows a smaller increase over The striking difference between the pattern of metabolites in a normal cycle and in the second and third trimesters of pregnancy is the change from oestriol 3-glucuronide to oestriol 1 6a-glucuronide as the major urinary oestrogen. Figs. 6(a) and 6(b) also demonstrate a tendency for the ratio of oestriol 16a-glucuronide to oestrone 3-glucuronide to increase throughout most of pregnancy.
Discussion
Cross-reactions of related oestrogen glucuronides were sufficiently low to have minimal effect on the accuracy of the five oestrogen assays. Unconjugated oestrogens, although showing rather higher crossreactions, are present in urine only as about 1 % of the total oestrogens (Kunzig & Geiger, 1976) , and therefore probably do not interfere to a significant extent. A constant recovery of measured steroid over a range of urine dilutions was taken as further evidence that interference from cross-reacting steroids was minimal. Provided that urine was assayed at a dilution of at least 20-fold, urine blanks were not significantly different from buffer blanks.
External recovery experiments did not reveal a bias of scale or of zero bias in measured steroid. It therefore appeared that the five oestrogen assays would give valid results when applied directly to diluted urine.
Radioimmunoassay of oestrogen glucuronides in menstrual-cycle urine resulted in values for 'totalled Vol. 177 oestrogens' which were considerably higher than total oestrogen values obtained by chemical methods (Brown et al., 1968) . Possibly there is a discrepancy in the radioimmunoassay method due to interference from cross-reacting steroids or a positive blank effect from the urine sample which has not been revealed by the specificity or recovery studies. However, the interference would have to be very great indeed to account for the radioimmunoassay result being up to 3 times that of chemical methods. Similar discrepancies have been reported by Adlercreutz et al. (1976) The pattern of excretion of oestrogen glucuronides during the menstrual cycle is similar to that determined by a chemical method (Johansson et al., 1971) , the peak of total oestrogen usually occurring on the same day or the day before that of the lutropin peak. The present work indicates that certain oestrogen glucuronides give an earlier warning of impending ovulation than others. Also that the temporal order ofexcretion ofthe various conjugates reflects different metabolism. For instance, enterohepatic circulation of oestriol results in the later appearance of oestriol 3-glucuronide in urine than other conjugates (Goebelsmann et al., 1966) .
In the clinical application of the techniques described it is more convenient, in practical terms, to measure one conjugate rather than-all five. Oestrone 3-glucuronide is probably the best conjugate to measure, since next to oestradiol 17,B-glucuronide it has the highest mid-cycle peak-to-baseline ratio, yet it is excreted in 5 times the amount of the latter and can be detected in 100-fold-diluted urine. Also an increase in oestrone 3-glucuronide tends to occur sooner than most other conjugates, and its excretion shows a comparatively low degree of variation between individuals.
The assays described can be carried out within 3 h; this would be of little advantage to the clinician if 24h urine specimens had to be collected. The present work shows that valid results can be obtained from random urine specimens by expressing results either as hourly rates of excretion or as oestrogen/creatinine ratios. Already an oestrogen/creatinine ratio has proved to be a satisfactory parameter for monitoring pregnancy urine (Metcalf & Hunt, 1976; Rao, 1977) .
In addition, the oestrone 3-glucuronide/pregnanediol 3-glucuronide ratio offers a simple alternative for the prediction of ovulation.
The results on oestrogen glucuronide excretion during pregnancy are of a preliminary nature. As with menstrual-cycle urine, the mass of oestrogen glucuronides in pregnancy 24h urines determined by radioimmunoassay showed higher values than those reported for chemical methods. In term urine, the values found for oestrone 3-glucuronide and oestriol 16a-glucuronide range from 53 to 128 % greater than those reported by Ahmed & Kellie (1972) and 8 to 41 % greater than those reported by Tikkanen (1972) . However, the relative proportions of oestrone 3-glucuronide, oestriol 3-glucuronide and oestriol 16a-glucuronide at term (8, 18 and 74% respectively) were very similar to those determined by Ahmed & Kellie (1972) (5, 20 and 75% respectively). The marked increase in the excretion of oestriol 16a-glucuronide reflects increased production of oestriol by the foetoplacental unit (for review see Kunzig & Geiger, 1976) . On the other hand the relatively constant mass of oestrone 3-glucuronide in pregnancy 24 h urines may relate to the fact that the source of approximately half the oestrone precursors is the maternal adrenals (Siiteri & MacDonald, 1966) . Oestrone 3-glucuronide excretion should therefore be less dependent on the state of the foetus than oestriol 16a-glucuronide excretion. If this is the case, then the ratio of oestriol 1 6a-glucuronide/oestrone 3-glucuronide should be a useful parameter for the monitoring of foetoplacental function.
